TY - JOUR AU - Bray, F. AU - Ferlay, J. AU - Soerjomataram, I. AU - Siegel, R. L. AU - Torre, L. A. AU - Jemal, A. PY - 2018 DA - 2018// TI - Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA Cancer J Clin VL - 68 UR - https://doi.org/10.3322/caac.21492 DO - 10.3322/caac.21492 ID - Bray2018 ER - TY - JOUR AU - Hayata, E. AU - Seto, K. AU - Haga, K. AU - Kitazawa, T. AU - Matsumoto, K. AU - Morita, M. AU - Hasegawa, T. PY - 2015 DA - 2015// TI - Cost of illness of the cervical cancer of the uterus in Japan--a time trend and future projections JO - BMC Health Serv Res VL - 15 UR - https://doi.org/10.1186/s12913-015-0776-5 DO - 10.1186/s12913-015-0776-5 ID - Hayata2015 ER - TY - JOUR AU - Yamagami, W. AU - Nagase, S. AU - Takahashi, F. AU - Ino, K. AU - Hachisuga, T. AU - Aoki, D. AU - Katabuchi, H. PY - 2017 DA - 2017// TI - Clinical statistics of gynecologic cancers in Japan JO - J Gynecol Oncol VL - 28 UR - https://doi.org/10.3802/jgo.2017.28.e32 DO - 10.3802/jgo.2017.28.e32 ID - Yamagami2017 ER - TY - JOUR AU - Nagase, S. AU - Ohta, T. AU - Takahashi, F. AU - Enomoto, T. PY - 2019 DA - 2019// TI - Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: annual patients report for 2015 and annual treatment report for 2010 JO - J Obstet Gynaecol Res VL - 45 UR - https://doi.org/10.1111/jog.13863 DO - 10.1111/jog.13863 ID - Nagase2019 ER - TY - JOUR AU - Koh, W. J. AU - Abu-Rustum, N. R. AU - Bean, S. AU - Bradley, K. AU - Campos, S. M. AU - Cho, K. R. AU - Chon, H. S. AU - Chu, C. AU - Clark, R. AU - Cohn, D. PY - 2019 DA - 2019// TI - Cervical cancer, version 3.2019, NCCN clinical practice guidelines in oncology JO - J Natl Compr Canc Netw VL - 17 UR - https://doi.org/10.6004/jnccn.2019.0001 DO - 10.6004/jnccn.2019.0001 ID - Koh2019 ER - TY - JOUR AU - Ebina, Y. AU - Mikami, M. AU - Nagase, S. AU - Tabata, T. AU - Kaneuchi, M. AU - Tashiro, H. AU - Mandai, M. AU - Enomoto, T. AU - Kobayashi, Y. AU - Katabuchi, H. PY - 2019 DA - 2019// TI - Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer JO - Int J Clin Oncol VL - 24 UR - https://doi.org/10.1007/s10147-018-1351-y DO - 10.1007/s10147-018-1351-y ID - Ebina2019 ER - TY - JOUR AU - Jung, P. S. AU - Kim, D. Y. AU - Lee, S. W. AU - Park, J. Y. AU - Suh, D. S. AU - Kim, J. H. AU - Kim, Y. M. AU - Kim, Y. T. AU - Nam, J. H. PY - 2015 DA - 2015// TI - Clinical role of adjuvant chemotherapy after radical hysterectomy for FIGO stage IB-IIA cervical cancer: comparison with adjuvant RT/CCRT using inverse-probability-of-treatment weighting JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0132298 DO - 10.1371/journal.pone.0132298 ID - Jung2015 ER - TY - JOUR AU - Matsuo, K. AU - Shimada, M. AU - Aoki, Y. AU - Sakamoto, M. AU - Takeshima, N. AU - Fujiwara, H. AU - Matsumoto, T. AU - Mikami, M. AU - Sugiyama, T. PY - 2017 DA - 2017// TI - Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: systemic chemotherapy versus pelvic irradiation JO - Int J Cancer VL - 141 UR - https://doi.org/10.1002/ijc.30793 DO - 10.1002/ijc.30793 ID - Matsuo2017 ER - TY - JOUR AU - Takekuma, M. AU - Kasamatsu, Y. AU - Kado, N. AU - Kuji, S. AU - Tanaka, A. AU - Takahashi, N. AU - Abe, M. AU - Hirashima, Y. PY - 2016 DA - 2016// TI - Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy JO - Int J Clin Oncol VL - 21 UR - https://doi.org/10.1007/s10147-016-0955-3 DO - 10.1007/s10147-016-0955-3 ID - Takekuma2016 ER - TY - JOUR AU - Shoji, T. AU - Takatori, E. AU - Furutake, Y. AU - Takada, A. AU - Nagasawa, T. AU - Omi, H. AU - Kagabu, M. AU - Honda, T. AU - Miura, F. AU - Takeuchi, S. PY - 2016 DA - 2016// TI - Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass JO - Int J Clin Oncol VL - 21 UR - https://doi.org/10.1007/s10147-016-1008-7 DO - 10.1007/s10147-016-1008-7 ID - Shoji2016 ER - TY - JOUR AU - Matsumura, M. AU - Takeshima, N. AU - Ota, T. AU - Omatsu, K. AU - Sakamoto, K. AU - Kawamata, Y. AU - Umayahara, K. AU - Tanaka, H. AU - Akiyama, F. AU - Takizawa, K. PY - 2010 DA - 2010// TI - Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for stage IB2-IIB cervical cancer--irinotecan and platinum chemotherapy JO - Gynecol Oncol VL - 119 UR - https://doi.org/10.1016/j.ygyno.2010.07.031 DO - 10.1016/j.ygyno.2010.07.031 ID - Matsumura2010 ER - TY - JOUR AU - Yamaguchi, S. AU - Nishimura, R. AU - Yaegashi, N. AU - Kiguchi, K. AU - Sugiyama, T. AU - Kita, T. AU - Kubushiro, K. AU - Kokawa, K. AU - Hiura, M. AU - Mizutani, K. PY - 2012 DA - 2012// TI - Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065) JO - Oncol Rep VL - 28 UR - https://doi.org/10.3892/or.2012.1814 DO - 10.3892/or.2012.1814 ID - Yamaguchi2012 ER - TY - JOUR AU - Mori, T. AU - Makino, H. AU - Okubo, T. AU - Fujiwara, Y. AU - Sawada, M. AU - Kuroboshi, H. AU - Tsubamoto, H. AU - Murakoshi, H. AU - Motohashi, T. AU - Kitawaki, J. PY - 2019 DA - 2019// TI - Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: a Kansai Clinical Oncology Group study (KCOG-G1201) JO - J Obstet Gynaecol Res VL - 45 UR - https://doi.org/10.1111/jog.13885 DO - 10.1111/jog.13885 ID - Mori2019 ER - TY - JOUR AU - Matoda, M. AU - Takeshima, N. AU - Michimae, H. AU - Iwata, T. AU - Yokota, H. AU - Torii, Y. AU - Yamamoto, Y. AU - Takehara, K. AU - Nishio, S. AU - Takano, H. PY - 2018 DA - 2018// TI - Postoperative chemotherapy for node-positive cervical cancer: results of a multicenter phase II trial (JGOG1067) JO - Gynecol Oncol VL - 149 UR - https://doi.org/10.1016/j.ygyno.2018.04.009 DO - 10.1016/j.ygyno.2018.04.009 ID - Matoda2018 ER - TY - JOUR AU - Abou-Taleb, H. A. AU - Koshiyama, M. AU - Matsumura, N. AU - Baba, T. AU - Yamaguchi, K. AU - Hamanishi, J. AU - Abiko, K. AU - Yamanoi, K. AU - Murakami, R. AU - Horikawa, N. PY - 2016 DA - 2016// TI - Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer JO - J Int Med Res VL - 44 UR - https://doi.org/10.1177/0300060515591858 DO - 10.1177/0300060515591858 ID - Abou-Taleb2016 ER - TY - JOUR AU - Takano, M. AU - Sugiyama, T. PY - 2017 DA - 2017// TI - UGT1A1 polymorphisms in cancer: impact on irinotecan treatment JO - Pharmgenomics Pers Med VL - 10 ID - Takano2017 ER - TY - JOUR AU - Horikawa, N. AU - Baba, T. AU - Matsumura, N. AU - Murakami, R. AU - Abiko, K. AU - Hamanishi, J. AU - Yamaguchi, K. AU - Koshiyama, M. AU - Yoshioka, Y. AU - Konishi, I. PY - 2015 DA - 2015// TI - Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1703-1 DO - 10.1186/s12885-015-1703-1 ID - Horikawa2015 ER - TY - JOUR AU - Seagle, B. L. AU - Shilpi, A. AU - Buchanan, S. AU - Goodman, C. AU - Shahabi, S. PY - 2017 DA - 2017// TI - Low-grade and high-grade endometrial stromal sarcoma: a National Cancer Database study JO - Gynecol Oncol VL - 146 UR - https://doi.org/10.1016/j.ygyno.2017.05.036 DO - 10.1016/j.ygyno.2017.05.036 ID - Seagle2017 ER - TY - JOUR AU - Hothorn, T. AU - Hornik, K. AU - Zeileis, A. PY - 2006 DA - 2006// TI - Unbiased recursive partitioning: a conditional inference framework JO - J Comput Graph Stat VL - 15 UR - https://doi.org/10.1198/106186006X133933 DO - 10.1198/106186006X133933 ID - Hothorn2006 ER - TY - JOUR AU - Kwon, J. AU - Eom, K. Y. AU - Kim, Y. S. AU - Park, W. AU - Chun, M. AU - Lee, J. AU - Kim, Y. B. AU - Yoon, W. S. AU - Kim, J. H. AU - Choi, J. H. PY - 2018 DA - 2018// TI - The prognostic impact of the number of metastatic lymph nodes and a new prognostic scoring system for recurrence in early-stage cervical cancer with high risk factors: a multicenter cohort study (KROG 15-04) JO - Cancer Res Treat VL - 50 UR - https://doi.org/10.4143/crt.2017.346 DO - 10.4143/crt.2017.346 ID - Kwon2018 ER - TY - JOUR AU - Park, J. W. AU - Bae, J. W. PY - 2016 DA - 2016// TI - Prognostic significance of positive lymph node number in early cervical cancer JO - Mol Clin Oncol VL - 4 UR - https://doi.org/10.3892/mco.2016.837 DO - 10.3892/mco.2016.837 ID - Park2016 ER - TY - JOUR AU - Inoue, T. AU - Morita, K. PY - 1990 DA - 1990// TI - The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB JO - Cancer VL - 65 UR - https://doi.org/3.0.CO;2-M DO - 3.0.CO;2-M ID - Inoue1990 ER - TY - JOUR AU - Sakuragi, N. AU - Satoh, C. AU - Takeda, N. AU - Hareyama, H. AU - Takeda, M. AU - Yamamoto, R. AU - Fujimoto, T. AU - Oikawa, M. AU - Fujino, T. AU - Fujimoto, S. PY - 1999 DA - 1999// TI - Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy JO - Cancer VL - 85 UR - https://doi.org/3.0.CO;2-2 DO - 3.0.CO;2-2 ID - Sakuragi1999 ER - TY - JOUR AU - Queiroz, A. C. M. AU - Fabri, V. AU - Mantoan, H. AU - Sanches, S. M. AU - Guimaraes, A. P. G. AU - Ribeiro, A. R. G. AU - Nogueira Silveira Lima, J. P. AU - Chen, M. J. AU - Baiocchi, G. AU - Costa, A. PY - 2019 DA - 2019// TI - Risk factors for pelvic and distant recurrence in locally advanced cervical cancer JO - Eur J Obstet Gynecol Reprod Biol VL - 235 UR - https://doi.org/10.1016/j.ejogrb.2019.01.028 DO - 10.1016/j.ejogrb.2019.01.028 ID - Queiroz2019 ER - TY - JOUR AU - Pasternak, A. L. AU - Ward, K. M. AU - Luzum, J. A. AU - Ellingrod, V. L. AU - Hertz, D. L. PY - 2017 DA - 2017// TI - Germline genetic variants with implications for disease risk and therapeutic outcomes JO - Physiol Genomics VL - 49 UR - https://doi.org/10.1152/physiolgenomics.00035.2017 DO - 10.1152/physiolgenomics.00035.2017 ID - Pasternak2017 ER - TY - JOUR AU - Liu, D. AU - Li, J. AU - Gao, J. AU - Li, Y. AU - Yang, R. AU - Shen, L. PY - 2017 DA - 2017// TI - Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis JO - BMC Cancer VL - 17 UR - https://doi.org/10.1186/s12885-017-3406-2 DO - 10.1186/s12885-017-3406-2 ID - Liu2017 ER - TY - JOUR AU - Wang, Y. AU - Shen, L. AU - Xu, N. AU - Wang, J. W. AU - Jiao, S. C. AU - Liu, Z. Y. AU - Xu, J. M. PY - 2012 DA - 2012// TI - UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil JO - World J Gastroenterol VL - 18 UR - https://doi.org/10.3748/wjg.v18.i45.6635 DO - 10.3748/wjg.v18.i45.6635 ID - Wang2012 ER - TY - JOUR AU - Dias, M. M. AU - Pignon, J. P. AU - Karapetis, C. S. AU - Boige, V. AU - Glimelius, B. AU - Kweekel, D. M. AU - Lara, P. N. AU - Laurent-Puig, P. AU - Martinez-Balibrea, E. AU - Paez, D. PY - 2014 DA - 2014// TI - The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis JO - Pharmacogenomics J VL - 14 UR - https://doi.org/10.1038/tpj.2014.16 DO - 10.1038/tpj.2014.16 ID - Dias2014 ER - TY - JOUR AU - Takano, M. AU - Yamamoto, K. AU - Tabata, T. AU - Minegishi, Y. AU - Yokoyama, T. AU - Hirata, E. AU - Ikeda, T. AU - Shimada, M. AU - Yamada, K. AU - Morita, S. PY - 2016 DA - 2016// TI - Impact of UGT1A1 genotype upon toxicities of combination with low-dose irinotecan plus platinum JO - Asia Pac J Clin Oncol VL - 12 UR - https://doi.org/10.1111/ajco.12453 DO - 10.1111/ajco.12453 ID - Takano2016 ER - TY - JOUR AU - Hirasawa, A. AU - Zama, T. AU - Akahane, T. AU - Nomura, H. AU - Kataoka, F. AU - Saito, K. AU - Okubo, K. AU - Tominaga, E. AU - Makita, K. AU - Susumu, N. PY - 2013 DA - 2013// TI - Polymorphisms in the UGT1A1 gene predict adverse effects of irinotecan in the treatment of gynecologic cancer in Japanese patients JO - J Hum Genet VL - 58 UR - https://doi.org/10.1038/jhg.2013.105 DO - 10.1038/jhg.2013.105 ID - Hirasawa2013 ER - TY - JOUR AU - Man, F. M. AU - Goey, A. K. L. AU - Schaik, R. H. N. AU - Mathijssen, R. H. J. AU - Bins, S. PY - 2018 DA - 2018// TI - Individualization of Irinotecan treatment: a review of pharmacokinetics, pharmacodynamics, and pharmacogenetics JO - Clin Pharmacokinet VL - 57 UR - https://doi.org/10.1007/s40262-018-0644-7 DO - 10.1007/s40262-018-0644-7 ID - Man2018 ER -